AR060225A1 - Proceso para preparar 6,7- dihidro-5h-imidazo (1,5-a) piridin -8- ona - Google Patents

Proceso para preparar 6,7- dihidro-5h-imidazo (1,5-a) piridin -8- ona

Info

Publication number
AR060225A1
AR060225A1 ARP070101337A ARP070101337A AR060225A1 AR 060225 A1 AR060225 A1 AR 060225A1 AR P070101337 A ARP070101337 A AR P070101337A AR P070101337 A ARP070101337 A AR P070101337A AR 060225 A1 AR060225 A1 AR 060225A1
Authority
AR
Argentina
Prior art keywords
formula
compound
imidazo
converted
pyridin
Prior art date
Application number
ARP070101337A
Other languages
English (en)
Original Assignee
Speedel Experimenta Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Experimenta Ag filed Critical Speedel Experimenta Ag
Publication of AR060225A1 publication Critical patent/AR060225A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicacion 1: Un proceso para preparar 6,7-dihidro-5H-imidazo[1,5-a]piridin-8-ona (formula 1) caracterizado porque un compuesto de formula 8, donde R4 es un grupo protector adecuado que se puede eliminar por hidrogenacion en determinadas condiciones, por ejemplo bencilo o 4-metoxibencilo, se hidrogena selectivamente en la funcionalidad ciano para obtener un compuesto de formula 9 o el clorhidrato de 2-hidroximetilpiridin-3-ol (formula 8') se convierte, por O-alquilacion catalizada por transferencia de fase selectiva del alcohol en la posicion 3 con un R4-haluro, seguido por la mesilacion del alcohol primario, la reaccion con ftalimida de potasio y el posterior tratamiento con solucion acuosa de dimetilamina, preferentemente solucion acuosa de dimetilamina al 40%, en un compuesto de formula 9, 2b) el compuesto de formula 9 se convierte por reaccion con ácido formico para obtener el compuesto de formula 10, 2c) el compuesto de formula 10 se convierte en el compuesto de formula 11, y 2d) el compuesto de formula 11 se hidrogena para obtener 6,7-dihidro-5H-imidazo[1,5-a]piridin-8-ona (formula 1).
ARP070101337A 2006-03-31 2007-03-29 Proceso para preparar 6,7- dihidro-5h-imidazo (1,5-a) piridin -8- ona AR060225A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5352006 2006-03-31

Publications (1)

Publication Number Publication Date
AR060225A1 true AR060225A1 (es) 2008-06-04

Family

ID=38166492

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101337A AR060225A1 (es) 2006-03-31 2007-03-29 Proceso para preparar 6,7- dihidro-5h-imidazo (1,5-a) piridin -8- ona

Country Status (10)

Country Link
US (1) US20090118512A1 (es)
EP (1) EP2001850A1 (es)
JP (1) JP2009531391A (es)
CN (1) CN101410377A (es)
AR (1) AR060225A1 (es)
BR (1) BRPI0709695A2 (es)
CA (1) CA2647616A1 (es)
IL (1) IL194384A0 (es)
TW (1) TW200804284A (es)
WO (1) WO2007113235A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1329394C (zh) * 2000-11-17 2007-08-01 武田药品工业株式会社 新咪唑衍生物、其制备方法及其用途
TW200612947A (en) * 2004-05-28 2006-05-01 Speedel Experimenta Ag Organic compounds
FR2883286B1 (fr) * 2005-03-16 2008-10-03 Sanofi Aventis Sa NOUVEAUX DERIVES D'IMIDAZO[1,5-a]PYRIDINES, INHIBITEURS DE FGFs, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT

Also Published As

Publication number Publication date
CN101410377A (zh) 2009-04-15
JP2009531391A (ja) 2009-09-03
IL194384A0 (en) 2009-08-03
WO2007113235A1 (en) 2007-10-11
CA2647616A1 (en) 2007-10-11
EP2001850A1 (en) 2008-12-17
TW200804284A (en) 2008-01-16
US20090118512A1 (en) 2009-05-07
BRPI0709695A2 (pt) 2011-07-19

Similar Documents

Publication Publication Date Title
MX2010004819A (es) Derivados de [1h-pirazolo[3,4-b]piridin-4-il]-fenilo o piridin-2-ilo como proteina cinasa c-theta.
NZ600639A (en) Processes for the manufacture of a pharmaceutically active agent
BRPI0612957B8 (pt) composto, processos de preparação de compostos, composição farmacêutica e uso de um composto
BR112012006858A2 (pt) metodo de aperfeicoamento do desempenho de impressao em placas de impressao flexografica
ECSP13012892A (es) IMIDAZO[5,1-f][1,2,4]TRIAZINAS PARA EL TRATAMIENTO DE TRASTORNOS NEUROLÓGICOS
CL2010001407A1 (es) Compuestos derivados de purina y pirimidina sustituidos; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar enfermedades virales tales como hepatitis c, dengue, fiebre amarilla, polio, hepatitis a, entre otras.
WO2008062905A3 (en) Heteromonocyclic compound and use thereof
NZ602862A (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
NO20081367L (no) Fenyl- og pyridyl-1,2,4-oksadiazolonderivater med fenylgruppe, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytika
PE20020911A1 (es) Derivados de indol como agonistas de 5ht2
CL2008003577A1 (es) Compuestos derivados de imidazo[1,5-a] pirido[3,2-e]pirazina, 2, 6, 7, 9 tetrasustituidos; inhibidores de fosfodiesterasa 10; procedimiento de preparación; composición farmacéutica que comprende a dichos compuestos; y su uso para tratar enfermedades relacionadas con el sistema nervioso central, obesidad y trastornos del metabolismo.
MX2013000773A (es) Procedimiento de preparacion de derivados de amino-benzoil-benzofu rano.
MX2009000169A (es) Derivados de purinona como agonistas de hm74a.
UY31554A1 (es) Nuevos inhibidores de acetil coenzima a carboxilasa y usos en tratamientos de obesidad y diabetes mellitus
AR072586A1 (es) Derivados de sulfamidas sustituidas, procesos para su preparacion y su uso para el tratamiento de trastornos del sistema nervioso y del metabolismo.
DOP2001000288A (es) Formas de sal de amida de acido3-(4-bromo-2,6-difluoro-benciloxi)-5-(3-(4-pirrolidin - 1 - ilbutil) ureidoisitiazol - 4 - carboxilico y método de producción
BR112013022671A2 (pt) processo para a preparação de aminas primárias, e, uso de um catalisador complexo
AR047544A1 (es) Proceso para la preparacion de compuestos de triazol sustituidos
AR053517A1 (es) Proceso para la preparacion de compuestos de tetrazolilo, uso de los mismos en el tratamiento de enfermedades circulatorias y formulaciones farmaceuticas que los contienen.
BRPI0511956A (pt) processo para a preparação dos compostos, e, intermediários de sìntese
WO2006114676A8 (en) A process for the preparation of rupatadine
AR059286A1 (es) Proceso para preparar voriconazol, una forma polimorfica de un intermediario del mismo y su uso
EA201070228A1 (ru) Тразодон и гидрохлорид тразодона в очищенной форме
EP2103610A4 (en) SALTS OF IMIDAZOLE-5-CARBOXYLIC ACID DERIVATIVES, METHOD OF MANUFACTURE AND USE THEREOF
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
FB Suspension of granting procedure